DE68906122D1 - Verbindungen zur behandlung von harninkontinenz. - Google Patents

Verbindungen zur behandlung von harninkontinenz.

Info

Publication number
DE68906122D1
DE68906122D1 DE8989119480T DE68906122T DE68906122D1 DE 68906122 D1 DE68906122 D1 DE 68906122D1 DE 8989119480 T DE8989119480 T DE 8989119480T DE 68906122 T DE68906122 T DE 68906122T DE 68906122 D1 DE68906122 D1 DE 68906122D1
Authority
DE
Germany
Prior art keywords
lower alkyl
compounds
hydroxy
hydrogen
treating urinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989119480T
Other languages
English (en)
Other versions
DE68906122T2 (de
Inventor
Christer Sjoegren
Rene Mollberg
Sten Kelfve
Bertil Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of DE68906122D1 publication Critical patent/DE68906122D1/de
Publication of DE68906122T2 publication Critical patent/DE68906122T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Dowels (AREA)
  • Underground Structures, Protecting, Testing And Restoring Foundations (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Discharge Heating (AREA)
  • Medicinal Preparation (AREA)
  • Finger-Pressure Massage (AREA)
  • Table Equipment (AREA)
DE68906122T 1988-11-04 1989-10-20 Verbindungen zur Behandlung von Harninkontinenz. Expired - Fee Related DE68906122T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8804003A SE8804003D0 (sv) 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence

Publications (2)

Publication Number Publication Date
DE68906122D1 true DE68906122D1 (de) 1993-05-27
DE68906122T2 DE68906122T2 (de) 1997-05-22

Family

ID=20373858

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68906122T Expired - Fee Related DE68906122T2 (de) 1988-11-04 1989-10-20 Verbindungen zur Behandlung von Harninkontinenz.

Country Status (22)

Country Link
EP (1) EP0367040B1 (de)
JP (1) JPH02218652A (de)
KR (1) KR900007407A (de)
CN (1) CN1043700A (de)
AT (1) ATE88460T1 (de)
AU (1) AU628879B2 (de)
CA (1) CA2001641A1 (de)
DD (1) DD289467A5 (de)
DE (1) DE68906122T2 (de)
DK (1) DK544689A (de)
ES (1) ES2054980T3 (de)
FI (1) FI895229A0 (de)
HU (1) HU202828B (de)
IE (1) IE63480B1 (de)
NO (1) NO894384L (de)
NZ (1) NZ231243A (de)
PH (1) PH27014A (de)
PT (1) PT92189B (de)
RU (1) RU1833370C (de)
SE (1) SE8804003D0 (de)
TW (1) TW197944B (de)
ZA (1) ZA898385B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
AU642582B2 (en) * 1991-02-25 1993-10-21 Eli Lilly And Company Treatment of lower urinary tract disorders
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
GB0328060D0 (en) * 2003-12-04 2004-01-07 Sod Conseils Rech Applic Botulinum toxin treatment
WO2016173817A1 (en) 2015-04-28 2016-11-03 Unilever Plc N-aralkylcarbonyl-piperazine and -homopiperazine compounds and personal care compositions comprising the same
MX368097B (es) * 2015-04-28 2019-09-19 Unilever Nv Compuestos de n-aralquilcarbonildiamina y composiciones para el cuidado personal que comprende los mismos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009144A (en) * 1935-07-23 Substituted amides of amphatic-
US2831892A (en) * 1956-03-22 1958-04-22 Searle & Co N-(3-isopropylaminopropyl) diphenyl-acetamide and processes
FR2319337A1 (fr) * 1975-07-30 1977-02-25 Fabre Sa Pierre Gem diaryles possedant une activite antiarythmique utile en therapeutique cardiovasculaire
FR2333501A2 (fr) * 1975-12-03 1977-07-01 Science Union & Cie Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2340724A2 (fr) * 1976-02-13 1977-09-09 Science Union & Cie Nouveaux diarylacetamides substitues, leurs procedes de preparation et les compositions pharmaceutiques en contenant
FR2421892A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Procede de synthese industrielle du n(n' ethyl pyrrolidino-2 methyl) aadiphenylahydroxy acetamide
FR2421891A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Obtention industrielle d'amides de la pyrrolidine ethyl amine
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
FI895229A0 (fi) 1989-11-03
EP0367040A1 (de) 1990-05-09
AU4439489A (en) 1990-05-10
DK544689D0 (da) 1989-11-01
RU1833370C (en) 1993-08-07
AU628879B2 (en) 1992-09-24
PT92189A (pt) 1990-05-31
NZ231243A (en) 1994-03-25
EP0367040B1 (de) 1993-04-21
HU895648D0 (en) 1990-01-28
ES2054980T3 (es) 1994-08-16
DD289467A5 (de) 1991-05-02
HUT51597A (en) 1990-05-28
ATE88460T1 (de) 1993-05-15
CA2001641A1 (en) 1990-05-04
NO894384D0 (no) 1989-11-03
PT92189B (pt) 1995-07-18
TW197944B (de) 1993-01-11
ZA898385B (en) 1990-07-25
IE893398L (en) 1990-05-04
DE68906122T2 (de) 1997-05-22
KR900007407A (ko) 1990-06-01
DK544689A (da) 1990-05-05
JPH02218652A (ja) 1990-08-31
NO894384L (no) 1990-05-07
SE8804003D0 (sv) 1988-11-04
IE63480B1 (en) 1995-05-03
HU202828B (en) 1991-04-29
PH27014A (en) 1993-02-01
CN1043700A (zh) 1990-07-11

Similar Documents

Publication Publication Date Title
SE9701144D0 (sv) Novel compounds, their use and preparation
ATE165510T1 (de) Methode zur hemmung der proliferation weiche muskelzellen und der restenose
ATE211466T1 (de) Depsipeptide, herstellung und anwendung
ATE205206T1 (de) Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
DE69009646T2 (de) Substituierte Harnstoffverbindungen, ihre Herstellung und Verwendung.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE68906122D1 (de) Verbindungen zur behandlung von harninkontinenz.
DE69628360D1 (de) Azepinonverbindungen zur Anwendung bei der Hemmung von ACE und NEP
FI971193A0 (fi) Hoidossa käyttökelpoisia kinoksaliinijohdannaisia
ES2088903T3 (es) Nuevos inhibidores de la s-adenosilmetionina descarboxilasa.
ATE58135T1 (de) 1,3-oxathianderivate.
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee